Kraig Biocraft Laboratories took possession of three strategically located mulberry fields on January 7 2026, creating an in‑house feedstock supply for its recombinant spider‑silk operation. The fields sit adjacent to the company’s existing rearing facilities, allowing the company to grow mulberry leaves on‑site and eliminate reliance on external suppliers.
The move is a key step in Kraig’s vertical‑integration strategy. By controlling the entire feed‑to‑silk chain—from leaf cultivation to silkworm rearing—the company can improve the consistency of the silkworm diet, reduce feed‑cost volatility, and accelerate the transition from proof‑of‑concept to commercial production. The new fields also enable year‑round rearing cycles, a prerequisite for meeting the growing demand from its first commercial customers in performance apparel and technical textiles.
Kraig’s production metrics underscore the scale of the operation. The company has already released more than one million BAM‑1 Alpha hybrid eggs and produced over 1,200 pounds of recombinant spider‑silk cocoon in 2024. The additional mulberry acreage is expected to support a continued increase in egg output and silk yield, positioning the company to meet the projected demand from its expanding customer base.
Financially, Kraig is operating with a limited cash runway that extends into 2027. The company’s strategy to cultivate mulberry leaves in‑house is designed to cut feed costs and improve margin stability. While specific cost‑saving figures are not disclosed, the company’s management has emphasized that the vertical integration will reduce variable feed expenses and improve operational leverage as production scales.
The company’s first commercial customers are concentrated in the performance apparel and technical textiles sectors, though specific names have not been disclosed. These early contracts signal market validation of the BAM‑1 Alpha product and provide a foundation for future growth in high‑performance applications such as aerospace composites and medical sutures.
Strategically, the acquisition of the mulberry fields positions Kraig to accelerate its commercial rollout, secure additional contracts, and strengthen its competitive edge in the emerging recombinant spider‑silk market. The move demonstrates the company’s commitment to scaling production while managing cash constraints, and it signals a critical step toward establishing a sustainable, vertically integrated supply chain.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.